Japan· JP-4490004F2028
アゼラスチン塩酸塩
A azelastine product containing アゼラスチン塩酸塩, registered in Japan by エーザイ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- アゼラスチン塩酸塩
- Manufacturer
- エーザイ
- Country
- Japan (JP)
- ATC code
- R06AX19
- ATC class
- Azelastine
- Defined daily dose
- 4 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
110 interactions on record for azelastine.
Graded by severity as the source publishes them — 110 info. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Azelastine · interactions on record
110 records
Same class
Other records under R06AX19
Azelastine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/09f4d699-ad3e-4a78-a857-e9a333427fb2 GET /v1/drugs/09f4d699-ad3e-4a78-a857-e9a333427fb2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "4490004F2028",
"category": "内用薬",
"price_yen": 7.3,
"generic_name": "アゼラスチン塩酸塩",
"product_name_jp": null,
"therapeutic_class": "4490",
"transitional_expiry": null
}See everything about azelastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.